iQ (intelligent Quantitation)-solutions software future proofs clinical and research radiology reporting with accurate, reproducible measurement of brain tissue and brain pathology across a range of neurological diseases.
“We demonstrate superior case-level sensitivity of a clinically integrated AI-based tool over standard radiology reports
(93.3% for the AI software vs 58.3% for a standard radiology report), relative to a consensus ground truth, with minimal loss of specificity.”
Please click here for our Nature npj publication ‘A Real-World Clinical Validation for AI-based MRI Monitoring in Multiple Sclerosis’.
iQ-MS – Next generation lesion activity assessment
(1) Quantitative, precise, lesion assessment [existing (red), new (blue), enlarging (green) lesions]
(2) Lesion number, volume and change from prior study.
iQ-MS – Next generation AI-based volumetrics
(1) Qualitative assessment – current standard of care
(2) IQ-MS: quantitative, precision volumetry in real-time
(3) Perfect segmentation, every time: excludes venous sinuses, other non-brain structures
SNAC’s iQ-MS™ produces real-time, customisable reports to monitor the changes in lesions and brain volume changes, including:
-
Measurement of FLAIR white matter hyperintensities (WMH) and contrast-enhancing T1 hyperintensities.
-
Comparison between present scan and previous timepoint to measure brain volume changes, WMH changes, and changes in thalamus.
-
Volumetric comparison to healthy cohort and patient cohort to display a more precise disease progression stage.
iQ-MS Report:
(1) Patient Information Table
(2) 3-axis display for quick QA of Segmentations
(3) Cross-Sectional Metrics
(4) Longitudinal Metrics
(5) Normative Plots Metric
